Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
The Journal of Infection|March 10, 2026
Effectiveness of the TYPHIBEV® (Vi-CRM197 conjugate) Vaccine Introduction in Nepal: A Test-Negative, Case-Control StudyDipesh Tamrakar, Sabin Bikram Shahi, Esther Jung, et al.Human Vaccines & Immunotherapeutics|December 26, 2024
The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income CountryRejwana Haque Pial, Ganesh Kumar Rai, Rajeev Shrestha, et al.International Journal of Cardiology. Heart & Vasculature|August 11, 2020
Cardiovascular disease trends in Nepal - An analysis of global burden of disease data 2017Sanju Bhattarai, Anu Aryal, Manita Pyakurel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2020
Spatial Heterogeneity of Enteric Fever in 2 Diverse Communities in NepalDipesh Tamrakar, Krista Vaidya, Alexander T Yu, et al.Plos Neglected Tropical Diseases|April 14, 2026
Correction: Impact of the COVID-19 pandemic and typhoid conjugate vaccine introduction on typhoid fever in NepalDipesh Tamrakar, Shiva Ram Naga, Esther Jung, et al.Plos Neglected Tropical Diseases|January 21, 2026
Impact of the COVID-19 pandemic and typhoid conjugate vaccine introduction on typhoid fever in NepalDipesh Tamrakar, Shiva Ram Naga, Esther Jung, et al.Mbio|August 18, 2025
Rapid, low-cost colorimetric detection of Salmonella Typhi bacteriophages for environmental surveillanceKesia Esther da Silva, Tuya Yokoyama, Shiva Ram Naga, et al.The Lancet. Infectious Diseases|December 23, 2021
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trialGanesh Kumar Rai, Tarun Saluja, Shipra Chaudhary, et al.The Lancet. Global Health|April 13, 2024
Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trialKaterina Rok Song, Ram Hari Chapagain, Dipesh Tamrakar, et al.Frontiers in Public Health|October 13, 2022
Perception towards vaccine effectiveness in controlling COVID-19 spread in rural and urban communities: A global surveyRoy R Marzo, Rajeev Shrestha, Binaya Sapkota, et al.Pageof 11